# OnCo record lysa (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/lysa/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "lysa" ;
  schema:name "LYSA (The Lymphoma Study Association)"@en ;
  schema:alternateName "LYSA"@en, "GELA"@en, "Groupe d'Etude des Lymphomes de l'Adulte"@en, "GOELAMS"@en, "LYSARC"@en ;
  schema:description "The French-Belgian lymphoma group, successor to GELA, whose LNH-98.5 trial made R-CHOP the standard for diffuse large B-cell lymphoma."@en ;
  schema:url <https://onco.cc/companies/lysa/>, <https://www.lysa-lymphoma.org> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.lysa-lymphoma.org> ;
  onco:tag "cooperative-group" ;
  schema:addressCountry "FR" ;
  onco:related <https://onco.cc/drugs/glofitamab/>, <https://onco.cc/drugs/axicabtagene-ciloleucel/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/bispecific-antibody/>, <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/fdg-pet/> ;
  onco:companies <https://onco.cc/companies/ielsg/>, <https://onco.cc/companies/german-lymphoma-alliance/> ;
  onco:institutions <https://onco.cc/institutions/institut-curie/>, <https://onco.cc/institutions/centre-henri-becquerel/> ;
  onco:trials <https://onco.cc/trials/prima/>, <https://onco.cc/trials/polarix/> ;
  onco:people <https://onco.cc/people/steven-le-gouill/>, <https://onco.cc/people/franck-morschhauser/>, <https://onco.cc/people/herve-tilly/> .
